Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function
Abstract The enzyme glucocerebrosidase (GCase) catalyses the hydrolysis of glucosylceramide to glucose and ceramide within lysosomes. Homozygous or compound heterozygous mutations in the GCase-encoding GBA1 gene cause the lysosomal storage disorder Gaucher disease, while heterozygous and homozygous...
Saved in:
| Main Authors: | Thomas Dal Maso, Chiara Sinisgalli, Gianluca Zilio, Elisa Franzin, Isabella Tessari, Els Pardon, Jan Steyaert, Steven Ballet, Elisa Greggio, Wim Versées, Nicoletta Plotegher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60134-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cryo-TEM structure of β-glucocerebrosidase in complex with its transporter LIMP-2
by: Jan Philipp Dobert, et al.
Published: (2025-03-01) -
Investigating the In Vivo Effects of Anti-Prion Protein Nanobodies on Prion Disease with AAV Vector
by: Jingjing Zhang, et al.
Published: (2025-02-01) -
Expression of Recombinant Human Glucocerebrosidase Protein in Sunflowers
by: Al-Dallee et al.
Published: (2019-03-01) -
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease.
by: Valentina Citro, et al.
Published: (2016-01-01) -
Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation.
by: Evelyn S Vincow, et al.
Published: (2024-11-01)